Jecho Biopharmaceuticals Co., Ltd.

This early-stage study tested a single injection of JL15003 in 17 adults whose glioblastoma brain cancer had returned after standard treatments. The main goal was to check safety and find the best dose, while also looking at whether the virus in the injection spreads in the body …

This study tested a new medicine called JL14002 against a standard treatment (ranibizumab) for wet age-related macular degeneration, a leading cause of vision loss. 443 adults aged 50-80 with active disease received injections into the eye. The main goal was to see if JL14002 imp…

This early-stage trial tested a single injection of JL18008, a lab-made protein designed to boost immune cells, in 40 healthy adults. The main goal was to check safety and how the body handles the drug. Researchers also measured changes in immune cell counts over 56 days. This is…